Serial microalbuminuria analysis in sepsis patients helps identify those requiring early treatment
Jaipur, Rajasthan: A new study published in the Journal of the Association of Physicians of India suggests that serial bedside urine albumin-creatinine analysis may aid in the early identification of individuals with sepsis who require early targeted treatment.
Despite breakthroughs in medical therapies, sepsis remains a significant healthcare risk in India and throughout the world. Because of the frequent delays in diagnosis, tailored medicines are less successful. There is no conventional strategy for detecting sepsis early in severely unwell individuals.
As a result, CL Nawal and colleagues undertook this study with the goal of determining the difference in microalbuminuria levels between sepsis and non-sepsis individuals. The decrease in levels over the first 24 hours was also compared to two sepsis scores, APACHE II (Acute Physiology and Chronic Health Evaluation) and SOFA (Sequential Organ Failure Assessment), for morbidity and death prediction.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.